Related Experiment Video

Updated: Aug 17, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Multiple sclerosis coinciding with Machado-Joseph disease

J E Röhl1, J D Lünemann, C Zimmer

  • 1Department of Neurology, University Hospital Charité, Humboldt University, Schumannstrasse 20/21, 10098 Berlin, Germany. jens.roehl@charite.de

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|July 5, 2005
PubMed

Insights

This case study examines a patient with Machado-Joseph disease, also known as spinocerebellar ataxia type 3, highlighting the overlap between neurodegenerative and autoimmune central nervous system disorders.

Area of Science:

  • Neuroimmunology
  • Neurodegeneration
  • Genetics

Background:

  • Multiple sclerosis (MS) is primarily characterized by inflammatory demyelination.
  • Recent research indicates significant neuronal damage in early MS stages.
  • Understanding the interplay between neuroinflammation and neurodegeneration is crucial.

Observation:

  • This report details an unusual case of a patient diagnosed with Machado-Joseph disease (MJD), also classified as spinocerebellar ataxia type 3 (SCA III).
  • The patient presented with overlapping symptoms or pathological features that prompted investigation into potential co-existing conditions.

Findings:

  • The coexistence of MJD/SCA III and potential autoimmune central nervous system (CNS) pathology was investigated.
  • The case challenges traditional views by exploring the intersection of a primary genetic neurodegenerative disorder with autoimmune disease mechanisms.

Implications:

  • This case provides novel insights into the complex pathogenesis of CNS disorders.
  • It suggests that neurodegenerative and autoimmune processes may be more interconnected than previously understood.
  • Further research is warranted to explore shared pathways and potential therapeutic targets in both MJD/SCA III and autoimmune CNS diseases.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...